BiOptix Diagnostics bioptix.com


Public lists: Medical Devices (6123)

BiOptix Diagnostics, aka BiOptix, has developed a new class of analytical biosensor instrumentation utilizing a patented high-throughput label-free technology known as ESPR - Enhanced Surface Plasmon Resonance. BiOptix instrumentation allows researchers to study label-free protein-protein and protein-small molecule interaction-with high sensitivity and high throughput. Applications include: Protein-small molecule interactions, protein-protein kinetics, antibody affinities and epitope mapping, ol...Show all

BiOptix Diagnostics, aka BiOptix, has developed a new class of analytical biosensor instrumentation utilizing a patented high-throughput label-free technology known as ESPR - Enhanced Surface Plasmon Resonance. BiOptix instrumentation allows research...Show all

Company (Acquired)

Phone: 303-545-5550

Fax:

1775 38th Street

Boulder, 80301
Colorado, United States

Latest News

See more competitors data Competitors
Total Funding Date of Last Funding
BiOptix Diagnostics $25.5M Sep 13, 2016

Web Traffic

Rank

Show (-10)

Engagement (PVPU)

Show (+1%)

Domain Authority Score
Show
Page Views Per Million (PVPM)
Show
Reach Per Million
Show

SEO Statistics

Domain Authority Score Show
Page Authority Score Show
No. External Links Show
No. Links Show

Web Traffic Statistics - Growth

Per Week Per Month Per 6 Months Per Year
Rank Login to see details
Page Views Per Million Login to see details
Page Views Per User Login to see details
Reach Per Million Login to see details

Related BiOptix Diagnostics Jobs

jobs by Indeed job
						search

Investors

Investor Investor Type Location Participating Rounds
Boulder VenturesVenture CapitalBoulder, Colorado, United StatesSeries C - IV, Series C - III, Series C - II, Option/Warrant, Series C, Series B, Series A - II, Series A
National Institutes of HealthGovernmentBethesda, Maryland, United StatesGrant - II
Peierls FoundationOtherNew York, New York, United StatesSeries B
Qualifying Therapeutic Discovery ProjectGovernmentWashington, DC, United StatesGrant
National Cancer InstituteGovernmentBethesda, Maryland, United StatesGrant - II
See all 10 investors
There is no Competitors data available for this company. Please select another tab.

Patents

Title Application Date Patent Date Status
(Patent / Application)
Polarization based interferometric detector Jun 27, 2013 Sep 09, 2014 Patent
Polarization based interferometric detector Apr 16, 2007 Jul 16, 2013 Patent
Polarization based interferometric detector Aug 05, 2014 Application